Table 1.

Demographic details of the patients and characteristics of their problematic proliferating infantile hemangioma.

Patient	Treatment	Age (months)	Size of main lesion (cm)	Site of main lesion	Number of lesions	Sex	Gestation (weeks)
1	Propranolol	5	10 × 8	Chest	1	F	36
2	Propranolol	11	4 × 3.5	Shoulder	1	F	41
3	Propranolol	3	10 × 8	Cheek/parotid	1	F	40
4	Propranolol	3	0.8 × 0.8	Upper lip	1	F	34
5	Propranolol	7	1 × 1	Lower eyelid	1	F	38
6	Propranolol	3	1.5 × 1.5	Nose	4	M	32
7	Propranolol	3	12 × 4	Elbow	1	F	40
8	Propranolol	3	2 × 3	Ear	1	F	36
9	Propranolol	2	2.5 × 5	Nose	1	M	39
10	Propranolol	3	8 × 5	Arm	1	F	39
11	Propranolol	5	2 × 1.5	Upper eyelid	1	F	40
12	Propranolol	4	8 × 8	Buttock	1	M	40
13	Surgery	7	2 × 2	Neck	1	M	33
14	Surgery	6	4 × 3	Buttock/back	2	M	35
15	Surgery	7	2.5 × 3.5	Labia majora	1	F	40
16	Surgery	8	2 × 2	Mons pubis	1	F	39
17	Surgery	12	3 × 3	Scalp	1	F	38
18	Surgery	4	2.5 × 2	Natal cleft	1	M	40
19	Surgery	9	2 × 2	Scalp	1	F	38
20	Surgery	5	3.5 × 3	Labia	1	F	40
21	Surgery	12	1.5 × 1.5	Eyebrow	2	F	40
22	Surgery	7	2.5 × 1.5	Temple	2	F	37
23	Surgery	6	2.5 × 2.5	Neck	2	F	41
24	Surgery	4	3 × 1.5	Scalp	1	M	40

M, male; F, female.